Icon Legend

Presentation Icons

Ticketed Event

Back

26 Views

Child Abuse & Neglect

Developmental and Behavioral Pediatrics

Developmental Biology

Health Equity/Social Determinants of Health

Health Services Research

Public Health

Trainee

Advancing Precision Medicine by Measuring ACEs, Toxic Stress, and Intervention Efficacy with Policy Implications

Closing Discussion

Sunday, April 27, 2025

8:25am – 8:30am HST

Location: Convention Center: 312

Speaker(s)

DR

David Reiner, Ph.D. (he/him/his)
California Health and Human Services, California, United States
LG

Laura M. Glynn, PhD (she/her/hers)
Professor of Psychology
Chapman University, United States
Pat Levitt, PhD
Provost Professor and Chief Scientific Officer
Children\'s Hospital Los Angeles and University of Southern California
Los Angeles, California, United States
Ariane Marie-Mitchell, MD, PhD, MPH (she/her/hers)
Associate Professor, Medical Director for Health Care Equity
Loma Linda University Children's Hospital
Claremont, California, United States
Sayantani B. Sindher, MD (she/her/hers)
Clinical Associate Professor
Stanford University School of Medicine
los altos, California, United States
Rachel Gilgoff, MD, FAAP (she/her/hers)
Advisor/ Consultant
Rachel Gilgoff
San Francisco, California, United States
George M. Slavich, Ph.D. (he/him/his)
Professor of Psychiatry and Biobehavioral Sciences
UCLA
Los Angeles, California, United States

Disclosure(s):

David Reiner, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Laura M. Glynn, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Pat Levitt, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Ariane Marie-Mitchell, MD, PhD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sayantani B. Sindher, MD: AIMMUNE (Terminated, July 1, 2024) (Products/Services: Research Support including clinical trials & the principal or named investigator); DBV (Ongoing) (Products/Services: Advisory Committee); FARE (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Genentech (Ongoing) (Products/Services: Advisory Committee); regeneron (Terminated, August 1, 2024) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Rachel Gilgoff, MD, FAAP: Civilian Live Beyond Campaign (Ongoing) (Products/Services: Consultant); Safe and Sound (Ongoing) (Products/Services: Consultant); Stronger Brains Inc. (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); UCAAN - UCLA/UCSF ACEs Aware Family Resilience Network (Ongoing) (Products/Services: Consultant); WndrHLTH (Ongoing) (Products/Services: Consultant, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)

George M. Slavich, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.